Currently submitted to: JMIRx Med
Date Submitted: Mar 17, 2026
Open Peer Review Period: Mar 27, 2026 - May 22, 2026
(currently open for review)
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Disease:Acute fibrinous and Organizing Pneumonia: Two Case Reports and Literature Review
ABSTRACT
Acute fibrinous and organising pneumonia (AFOP) is a rare subtype of idiopathic interstitial pneumonia, defined histologically by intra-alveolar fibrin accumulation and patchy organising fibrosis. Clinical and radiological manifestations are non-specific, frequently resulting in initial misclassification as community-acquired pneumonia; conclusive diagnosis requires histopathological examination of lung tissue. Timely diagnosis and early intervention are critical, with glucocorticoids remaining the mainstay of treatment.We describe two AFOP cases diagnosed at our centre, both of which responded favourably to glucocorticoid treatment. A systematic review of the pertinent literature was undertaken to provide further insights into the disease.Both patients initially presented with pneumonia that did not respond to antibiotics. Timely lung biopsy established the diagnosis of AFOP, and subsequent glucocorticoid therapy resulted in rapid clinical improvement.Clinicians should remain vigilant for AFOP. In patients with pneumonia unresponsive to antibiotics, early pathological assessment is essential for accurate diagnosis. Prompt initiation of appropriate therapy can substantially affect prognosis.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.